Vincent Andrews
Stock Analyst at Morgan Stanley
(3.83)
# 622
Out of 4,783 analysts
307
Total ratings
65.66%
Success rate
27.47%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Vincent Andrews
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALB Albemarle | Maintains: Underweight | $73 → $68 | $72.62 | -6.36% | 12 | Feb 18, 2025 | |
| BG Bunge Global | Maintains: Equal-Weight | $90 → $74 | $76.33 | -3.05% | 12 | Feb 11, 2025 | |
| ADM Archer-Daniels-Midland Company | Maintains: Equal-Weight | $52 → $47 | $47.91 | -1.89% | 18 | Feb 11, 2025 | |
| FMC FMC Corporation | Maintains: Equal-Weight | $70 → $46 | $41.92 | +9.73% | 15 | Feb 5, 2025 | |
| LYB LyondellBasell Industries | Maintains: Overweight | $90 → $85 | $70.42 | +20.70% | 10 | Feb 4, 2025 | |
| DOW Dow Inc. | Maintains: Equal-Weight | $46 → $43 | $34.52 | +24.57% | 16 | Jan 31, 2025 | |
| SHW The Sherwin-Williams Company | Maintains: Overweight | $450 → $405 | $341.22 | +18.69% | 23 | Jan 28, 2025 | |
| ECL Ecolab | Upgrades: Overweight | $263 → $280 | $250.95 | +11.58% | 15 | Jan 28, 2025 | |
| TROX Tronox Holdings | Maintains: Equal-Weight | $16 → $12 | $7.19 | +66.90% | 11 | Jan 13, 2025 | |
| CC The Chemours Company | Maintains: Equal-Weight | $25 → $22 | $13.66 | +61.11% | 15 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $80 | $57.75 | +38.53% | 16 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $94 | $74.48 | +26.21% | 9 | Oct 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $65 | $60.95 | +6.64% | 11 | Sep 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $240 → $280 | $293.06 | -4.46% | 13 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $70 → $85 | $77.24 | +10.05% | 17 | Aug 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Equal-Weight | $32 | $32.86 | -2.62% | 9 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $420 | $462.43 | -9.18% | 9 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $115 | $87.19 | +31.90% | 14 | Aug 1, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $143 → $155 | $108.16 | +43.31% | 16 | Jul 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $91 | $50.30 | +80.92% | 11 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $60 → $55 | $27.23 | +101.98% | 13 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $8.5 | $5.70 | +49.25% | 8 | Jan 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $45 → $57 | $37.06 | +53.80% | 4 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $160 | $76.61 | +108.85% | 1 | Apr 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | n/a | $114.77 | - | 9 | Dec 14, 2020 |
Albemarle
Feb 18, 2025
Maintains: Underweight
Price Target: $73 → $68
Current: $72.62
Upside: -6.36%
Bunge Global
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $90 → $74
Current: $76.33
Upside: -3.05%
Archer-Daniels-Midland Company
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $52 → $47
Current: $47.91
Upside: -1.89%
FMC Corporation
Feb 5, 2025
Maintains: Equal-Weight
Price Target: $70 → $46
Current: $41.92
Upside: +9.73%
LyondellBasell Industries
Feb 4, 2025
Maintains: Overweight
Price Target: $90 → $85
Current: $70.42
Upside: +20.70%
Dow Inc.
Jan 31, 2025
Maintains: Equal-Weight
Price Target: $46 → $43
Current: $34.52
Upside: +24.57%
The Sherwin-Williams Company
Jan 28, 2025
Maintains: Overweight
Price Target: $450 → $405
Current: $341.22
Upside: +18.69%
Ecolab
Jan 28, 2025
Upgrades: Overweight
Price Target: $263 → $280
Current: $250.95
Upside: +11.58%
Tronox Holdings
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $16 → $12
Current: $7.19
Upside: +66.90%
The Chemours Company
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $25 → $22
Current: $13.66
Upside: +61.11%
Jan 13, 2025
Maintains: Equal-Weight
Price Target: $100 → $80
Current: $57.75
Upside: +38.53%
Oct 21, 2024
Maintains: Equal-Weight
Price Target: $88 → $94
Current: $74.48
Upside: +26.21%
Sep 24, 2024
Maintains: Overweight
Price Target: $65
Current: $60.95
Upside: +6.64%
Jun 5, 2024
Maintains: Equal-Weight
Price Target: $240 → $280
Current: $293.06
Upside: -4.46%
Aug 7, 2023
Maintains: Equal-Weight
Price Target: $70 → $85
Current: $77.24
Upside: +10.05%
Aug 4, 2023
Reiterates: Equal-Weight
Price Target: $32
Current: $32.86
Upside: -2.62%
Aug 1, 2023
Reiterates: Overweight
Price Target: $420
Current: $462.43
Upside: -9.18%
Aug 1, 2023
Reiterates: Overweight
Price Target: $115
Current: $87.19
Upside: +31.90%
Jul 24, 2023
Maintains: Equal-Weight
Price Target: $143 → $155
Current: $108.16
Upside: +43.31%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $100 → $91
Current: $50.30
Upside: +80.92%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $60 → $55
Current: $27.23
Upside: +101.98%
Jan 11, 2023
Maintains: Equal-Weight
Price Target: $12 → $8.5
Current: $5.70
Upside: +49.25%
May 12, 2021
Maintains: Equal-Weight
Price Target: $45 → $57
Current: $37.06
Upside: +53.80%
Apr 12, 2021
Reinstates: Overweight
Price Target: $160
Current: $76.61
Upside: +108.85%
Dec 14, 2020
Downgrades: Equal-Weight
Price Target: n/a
Current: $114.77
Upside: -